Search research articles
Contact Us
Filters
Showing results (1231-1240 of 1,377) with videos related to
Page
of 138
Sort By:
Trials
|
August 12, 2023
The NightLife study - the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial
Katherine L Hull, Kate Bramham, Cassandra L Brookes, et al.
The New England Journal of Medicine
|
January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
Gust H Bardy, Kerry L Lee, Daniel B Mark, et al.
JACC. Heart Failure
|
December 30, 2014
Primary prevention implantable cardioverter-defibrillators and survival in older women
Emily P Zeitler, Anne S Hellkamp, Gregg C Fonarow, et al.
BMC Nephrology
|
September 10, 2016
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
Gemma Currie, Alison H M Taylor, Toshiro Fujita, et al.
The New England Journal of Medicine
|
September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failure
Jeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
Journal of Alzheimer'S Disease : JAD
|
July 12, 2020
Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769)
Amy C Ferguson, Rachana Tank, Laura M Lyall, et al.
Journal of the American College of Cardiology
|
December 20, 2005
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions
Jeroen J Bax, Theodore Abraham, S Serge Barold, et al.
Contemporary Clinical Trials
|
June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial
David Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
Annals of Internal Medicine
|
July 16, 2019
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis
Jeffrey T Ha, Brendon L Neuen, Lap P Cheng, et al.
Nature Communications
|
December 7, 2018
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Jingyi Liu, Zhibing Duan, Weijie Guo, et al.
Page
of 138
Search research articles
Search
Showing results (1231-1240 of 1,377) with videos related to
Sort By:
Page
of 138
Trials
|
August 12, 2023
The NightLife study - the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial
Katherine L Hull, Kate Bramham, Cassandra L Brookes, et al.
The New England Journal of Medicine
|
January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
Gust H Bardy, Kerry L Lee, Daniel B Mark, et al.
JACC. Heart Failure
|
December 30, 2014
Primary prevention implantable cardioverter-defibrillators and survival in older women
Emily P Zeitler, Anne S Hellkamp, Gregg C Fonarow, et al.
BMC Nephrology
|
September 10, 2016
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
Gemma Currie, Alison H M Taylor, Toshiro Fujita, et al.
The New England Journal of Medicine
|
September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failure
Jeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
Journal of Alzheimer'S Disease : JAD
|
July 12, 2020
Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769)
Amy C Ferguson, Rachana Tank, Laura M Lyall, et al.
Journal of the American College of Cardiology
|
December 20, 2005
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions
Jeroen J Bax, Theodore Abraham, S Serge Barold, et al.
Contemporary Clinical Trials
|
June 7, 2021
Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial
David Collister, Lawrence Mbuagbaw, Gordon Guyatt, et al.
Annals of Internal Medicine
|
July 16, 2019
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis
Jeffrey T Ha, Brendon L Neuen, Lap P Cheng, et al.
Nature Communications
|
December 7, 2018
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Jingyi Liu, Zhibing Duan, Weijie Guo, et al.
Page
of 138